Andere Kunden interessierten sich auch für
![Development of Novel Stimuli-Responsive Drug Delivery Systems]( "Development of Novel Stimuli-Responsive Drug Delivery Systems")
Development of Novel Stimuli-Responsive Drug Delivery Systems46,99 €![Fault Detection and Diagnosis via Improved Statistical Process Control]( "Fault Detection and Diagnosis via Improved Statistical Process Control")
Fault Detection and Diagnosis via Improved Statistical Process Control51,99 €![The Mosque: The Heart of Submission]( "The Mosque: The Heart of Submission")
The Mosque: The Heart of Submission41,99 €![TECHNOLOGICAL INNOVATIONS IN THE TEXTILE PRODUCTION PROCESS]( "TECHNOLOGICAL INNOVATIONS IN THE TEXTILE PRODUCTION PROCESS")
TECHNOLOGICAL INNOVATIONS IN THE TEXTILE PRODUCTION PROCESS26,99 €![The Christian Church as Social Process]( "The Christian Church as Social Process")
The Christian Church as Social Process36,99 €![Component Training and Process-oriented Approach in Note-taking]( "Component Training and Process-oriented Approach in Note-taking")
Component Training and Process-oriented Approach in Note-taking33,99 €![Process Philosophy and Political Ideology: The Social and Political Thought of Alfred North Whitehead and Charles Hartshorne]( "Process Philosophy and Political Ideology: The Social and Political Thought of Alfred North Whitehead and Charles Hartshorne")
Process Philosophy and Political Ideology: The Social and Political Thought of Alfred North Whitehead and Charles Hartshorne103,99 €
Dossier is a file document submitted based on the requirement of regulatory agency for the approval of drug product. It is essential to submit dossier file in the form of common technical document in USA and EUROPE. Generic drugs are approved under ANDA submission. An Abbreviated New Drug Application (ANDA) is an application for a U.S. generic drug approval for an existing licensed medication or approved drug.The ANDA contains data which when submitted to FDA's Center for Drug Evaluation and Research, Office of Generic Drugs, provides for the review and ultimate approval of a generic drug product. Once approved, an applicant may manufacture and market the generic drug product to provide a safe, effective, low cost alternative to the American public.The European Medicines Agency (EMA) is a European agency for the evaluation of medicinal products.The EMA operates as a decentralized scientific agency of the European Union and is responsible for the protection and promotion of human and animal health, specifically through the coordination of evaluation and monitoring of centrally authorized products and national referrals, developing technical guidance and providing scientific advice.